142 related articles for article (PubMed ID: 9477184)
1. Correlation of nuclear morphometry and immunostaining for p53 and proliferating cell nuclear antigen in transitional cell carcinoma of the bladder.
Ogura K; Fukuzawa S; Habuchi T; Ogawa O; Yoshida O
Int J Urol; 1997 Nov; 4(6):561-6. PubMed ID: 9477184
[TBL] [Abstract][Full Text] [Related]
2. PCNA and p53 in urinary bladder cancer: correlation with histological findings and prognosis.
Inagaki T; Ebisuno S; Uekado Y; Hirano A; Hiroi A; Shinka T; Ohkawa T
Int J Urol; 1997 Mar; 4(2):172-7. PubMed ID: 9179692
[TBL] [Abstract][Full Text] [Related]
3. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of p53 and proliferating cell nuclear antigen (PCNA) in bladder cancer: positive immunostaining and radiosensitivity.
Ogura K; Habuchi T; Yamada H; Ogawa O; Yoshida O
Int J Urol; 1995 Nov; 2(5):302-8. PubMed ID: 8749948
[TBL] [Abstract][Full Text] [Related]
5. [Expression of P21, p53 and proliferating cell nuclear antigen in human bladder cancer].
Ding Q; Zhang Y; Sun X
Zhonghua Bing Li Xue Za Zhi; 1997 Aug; 26(4):211-3. PubMed ID: 10072865
[TBL] [Abstract][Full Text] [Related]
6. Expression of immunohistochemical markers (PCNA, Ki-67, 486p and p53) on paraffin sections and their relation to the recurrence rate of superficial bladder tumors.
Vorreuther R; Hake R; Borchmann P; Lukowsky S; Thiele J; Engelmann U
Urol Int; 1997; 59(2):88-94. PubMed ID: 9392055
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical analysis of bcl-2 expression in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Urakami S; Honda S; Shirakawa H; Ishibe T
J Clin Pathol; 1996 May; 49(5):395-9. PubMed ID: 8707954
[TBL] [Abstract][Full Text] [Related]
8. [Clinical significance of stereological estimation of mean nuclear volume in human bladder carcinoma--further analysis of nuclear morphometric variables].
Fukuzawa S; Hashimura T; Horii Y; Yoshida O; Sasaki M
Hinyokika Kiyo; 1992 Dec; 38(12):1361-8. PubMed ID: 1288224
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical study of the proliferating ability and malignant potential of transitional cell carcinoma in the human urinary bladder.
Yoshikawa H; Ikeuchi T; Kai Y
Int J Urol; 1996 Jan; 3(1 Suppl):S32-4. PubMed ID: 24304017
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical studies of proliferating cell nuclear antigen and cathepsin D in transitional cell carcinoma of the urinary bladder.
Iizumi T; Iiyama T; Tanaka W; Okada E; Kamiyama Y; Okano Y; Sato S; Yazaki T; Umeda T; Imamura T
Urol Int; 1997; 59(2):81-7. PubMed ID: 9392054
[TBL] [Abstract][Full Text] [Related]
11. p53 protein expression and proliferative activity in imprints of superficial transitional cell carcinoma of the bladder.
Ioakim-Liossi A; Pantazopoulos D; Karakitsos P; Athanassiadou P; Aroni K; Giahnaki AE; Athanassiades P
Anal Quant Cytol Histol; 2000 Jun; 22(3):223-8. PubMed ID: 10872039
[TBL] [Abstract][Full Text] [Related]
12. Relationship of genetic instability with immunoreactivities for p53 protein and proliferating cell nuclear antigen in transitional cell carcinoma of the bladder.
Shiina H; Igawa M; Yagi H; Urakami S; Shirakawa H; Ishibe T
Eur Urol; 1996; 30(1):80-8. PubMed ID: 8854073
[TBL] [Abstract][Full Text] [Related]
13. The prognostic value of p53 nuclear overexpression and MIB-1 as a proliferative marker in transitional cell carcinoma of the bladder.
Popov Z; Hoznek A; Colombel M; Bastuji-Garin S; Lefrere-Belda MA; Bellot J; Abboh CC; Mazerolles C; Chopin DK
Cancer; 1997 Oct; 80(8):1472-81. PubMed ID: 9338472
[TBL] [Abstract][Full Text] [Related]
14. Expression and prognostic value of proliferating cell nuclear antigen in transitional cell carcinoma of the urinary bladder.
Chen G; Lin MS; Li RC
Urol Res; 1997; 25(1):25-30. PubMed ID: 9079742
[TBL] [Abstract][Full Text] [Related]
15. Proliferating cell nuclear antigen cyclin in human transitional cell carcinoma.
Hattori K; Uchida K; Akaza H; Koiso K; Nemoto R; Harada M
Br J Urol; 1995 Feb; 75(2):162-6. PubMed ID: 7850319
[TBL] [Abstract][Full Text] [Related]
16. [Growth fractions of bladder cancer determined by proliferating cell nuclear antigen immunostaining].
Kuroda H; Yasunaga Y; Takatera H; Fujioka H; Ohnishi A; Tsujimoto M
Hinyokika Kiyo; 1994 May; 40(5):379-82. PubMed ID: 7912881
[TBL] [Abstract][Full Text] [Related]
17. p53 and c-jun expression in urinary bladder transitional cell carcinoma: correlation with proliferating cell nuclear antigen (PCNA) histological grade and clinical stage.
Skopelitou A; Hadjiyannakis M; Dimopoulos D; Kamina S; Krikoni O; Alexopoulou V; Rigas C; Agnantis NJ
Eur Urol; 1997; 31(4):464-71. PubMed ID: 9187909
[TBL] [Abstract][Full Text] [Related]
18. Correlation of morphometry, nucleolar organizer regions, proliferating cell nuclear antigen and Ki67 antigen expression with grading and staging in urinary bladder carcinomas.
Krüger S; Müller H
Br J Urol; 1995 Apr; 75(4):480-4. PubMed ID: 7788260
[TBL] [Abstract][Full Text] [Related]
19. [Proliferative activity and p53 expression in transitional cell carcinoma of the urinary bladder].
Offner FA; Schäfer G; Hittmair A; Ofner D; Grünewald K; Weyrer K; Mattern D; Eberle J; Mikuz G; Feichtinger H
Verh Dtsch Ges Pathol; 1993; 77():241-6. PubMed ID: 7511289
[TBL] [Abstract][Full Text] [Related]
20. PCNA immunostaining as a valid alternative to tritiated thymidine-autoradiography to detect proliferative cell fraction in transitional cell bladder carcinomas.
Lavezzi AM; Terni L; Matturri L
In Vivo; 2000; 14(3):447-51. PubMed ID: 10904880
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]